Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05463341 · ClinicalTrials.gov registry record · NA
Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties
A NA study of Harm Reduction and Opiate Overdose, sponsored by Nationwide Children's Hospital.
- Active
- Registry status
- NA
- Development phase
- 2,400
- Enrollment target
- 1
- Study location
NCT05463341 is a NA study of Harm Reduction and Opiate Overdose that is active but no longer recruiting, run by Nationwide Children's Hospital. The registered enrollment target is 2,400 participants, above the 737-participant average among 7 other Harm Reduction trials with a reported enrollment target (226% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05463341, a NA study of Harm Reduction and Opiate Overdose, is active but no longer recruiting, sponsored by Nationwide Children's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 2,400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to investigate the feasibility, acceptability, and associated benefits and harms of integrating FTS education and distribution into select Project DAWN sites in rural and urban communities in Ohio.
Conditions Studied
Interventions
- BEHAVIORAL Fentanyl Test Strips
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,400 participants |
| Start Date | 2022-09-09 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05463341
The ClinicalTrials.gov registry entry for NCT05463341 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 2,400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 737-participant average among 7 other Harm Reduction trials with a reported enrollment target (226% higher). The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Harm Reduction appearing as the primary indexed condition, and to 1 intervention - of which Fentanyl Test Strips is the first listed.
NCT05463341 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05463341 about?
NCT05463341 is a clinical study titled "Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties". The purpose of the study is to investigate the feasibility, acceptability, and associated benefits and harms of integrating FTS education and distribution into select Project DAWN sites in rural and urban communities in Ohio.
What is the current status of trial NCT05463341?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,400 participants. The study started on 2022-09-09. Estimated completion is 2026-01-31.
What conditions does trial NCT05463341 study?
This clinical trial studies the following conditions: Harm Reduction, Opiate Overdose, Fentanyl Overdose.
What interventions are being tested in trial NCT05463341?
The interventions under investigation include: Fentanyl Test Strips (BEHAVIORAL).
Who is sponsoring clinical trial NCT05463341?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05463341 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Harm Reduction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention
RECRUITING · NA
-
A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students
RECRUITING · NA
-
Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
RECRUITING · NA
-
Electronic Harm Reduction Treatment for Alcohol
RECRUITING · Phase 3
-
Shelter HArm Reduction Evaluation
RECRUITING
-
Vending Machine Naloxone Distribution for Your Community (VENDY)
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.